Free Trial
→ Crypto’s crashing…but we’re still profiting (From Crypto Swap Profits) (Ad) Buy FDMT Stock  Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) SEC Filings & 10K Form

4D Molecular Therapeutics logo
$3.06 +0.15 (+5.15%)
Closing price 04:00 PM Eastern
Extended Trading
$2.98 -0.09 (-2.78%)
As of 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent 4D Molecular Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/24/2025
11:15 PM		4D Molecular Therapeutics (Filer)
Form EFFECT
03/10/2025
6:56 PM		4D Molecular Therapeutics (Issuer)
Kamal Fariborz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:57 PM		4D Molecular Therapeutics (Issuer)
Mehra Uneek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:58 PM		4D Molecular Therapeutics (Issuer)
Kim Robert Young (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:58 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:57 PM		4D Molecular Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
4:07 PM		4D Molecular Therapeutics (Filer)
Form POS AM
02/14/2025
5:30 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:09 PM		4D Molecular Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:40 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G/A
02/10/2025
4:28 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
7:37 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:36 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:15 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:05 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:15 PM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:13 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/13/2024
3:33 PM		4D Molecular Therapeutics (Issuer)
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:17 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:08 PM		4D Molecular Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
11/12/2024
11:12 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/06/2024
5:07 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G
11/04/2024
9:55 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/21/2024
3:11 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
09/18/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:22 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:13 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:17 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
4:11 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM		4D Molecular Therapeutics (Subject)
Bizily Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:07 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:44 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144/A
06/24/2024
4:39 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
06/07/2024
4:04 PM		4D Molecular Therapeutics (Filer)
Form 424B5
06/07/2024
4:07 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
7:45 PM		4D Molecular Therapeutics (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:10 PM		4D Molecular Therapeutics (Issuer)
GRAY SUSANNAH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:11 PM		4D Molecular Therapeutics (Issuer)
MILLIGAN JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:12 PM		4D Molecular Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:16 PM		4D Molecular Therapeutics (Issuer)
THEUER CHARLES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:17 PM		4D Molecular Therapeutics (Issuer)
Chacko Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:35 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:22 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:09 PM		4D Molecular Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2024
7:48 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FDMT) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored